| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/25/2010 | US20100047168 Soluble Zcytor 11 Cytokine Receptors |
| 02/25/2010 | US20100047163 Synthetic LDL as Targeted Drug Delivery Vehicle |
| 02/25/2010 | US20100047162 Methods of processing multi-phasic dispersons |
| 02/25/2010 | DE102009036995A1 Matrix auf Kollagenbasis zur Verwendung als Restaurationsmaterial und Verfahren zur Herstellung derselben Collagen-based matrix for use as a restorative material and method of producing same |
| 02/25/2010 | CA2734866A1 Complement inhibitors for treatment of injury from intracerebral hemorrhage |
| 02/25/2010 | CA2734838A1 T cell receptors and related materials and methods of use |
| 02/25/2010 | CA2734655A1 Combinations comprising bicyclic s1p lyase inhibitors |
| 02/25/2010 | CA2734585A1 Amino alcohol derivatives for the treatment of demyelinating peripheral neuropathies |
| 02/25/2010 | CA2734555A1 Multilayered blood product |
| 02/25/2010 | CA2734467A1 Hig2 and urlc10 epitope peptide and vaccines containing the same |
| 02/25/2010 | CA2734442A1 Methods and compositions for oral administration of proteins |
| 02/25/2010 | CA2734428A1 Susceptibility to hsp90-inhibitors |
| 02/25/2010 | CA2734325A1 Derivatives of apf and methods of use |
| 02/25/2010 | CA2733593A1 Use of ultrarapid acting insulin |
| 02/25/2010 | CA2733514A1 Formulation for oral administration of proteins |
| 02/25/2010 | CA2733508A1 Compounds for the treatment of peripheral neuropathies |
| 02/25/2010 | CA2732423A1 Recombinantly produced human factor viii and ix |
| 02/24/2010 | EP2157177A1 Preparative purification process for human furin |
| 02/24/2010 | EP2157176A1 Protein C Variants |
| 02/24/2010 | EP2157101A1 HSP peptides and analogs for modulation of immune responses via antigen presenting cells |
| 02/24/2010 | EP2157097A1 Specific binding agents of human angiopoietin-2 |
| 02/24/2010 | EP2157096A1 Amphipathic molecule, molecular aggregate comprising the amphipathic molecule, and use of the molecular aggregate |
| 02/24/2010 | EP2156846A1 Prophylactic or therapeutic agent for diarrhea |
| 02/24/2010 | EP2156843A2 Use of low-dose erythropoietin for the treatment of acute or chronic renal insufficiency and for the treatment of wounds |
| 02/24/2010 | EP2156842A1 Oral composition |
| 02/24/2010 | EP2156831A1 Augmented Cognitive Training |
| 02/24/2010 | EP2156820A1 Skin whitening agent |
| 02/24/2010 | EP2155894A2 Targeting host proteinases as a therapeutic strategy against viral and bacterial pathogens |
| 02/24/2010 | EP2155878A2 A method of treating abnormal angiogenesis via the bai family of proteins and their protein fragments |
| 02/24/2010 | EP2155874A2 Fusion proteins of collagen-binding domain and parathyroid hormone |
| 02/24/2010 | EP2155871A1 Ace2 polypeptide |
| 02/24/2010 | EP2155782A2 Mhc peptide complexes and uses thereof in infectious diseases |
| 02/24/2010 | EP2155776A2 Quaternary alkyl ammonium bacterial efflux pump inhibitors and therapeutic uses thereof |
| 02/24/2010 | EP2155775A2 Polybasic bacterial efflux pump inhibitors and therapeutic uses thereof |
| 02/24/2010 | EP2155237A2 Method for treatment of cancers or inflammatory diseases |
| 02/24/2010 | EP2155235A1 Oxygen-generating compositions for enhancing cell and tissue survival in vivo |
| 02/24/2010 | EP2155233A2 Synthetic peptide materials for joint reconstruction, repair and cushioning |
| 02/24/2010 | EP2155232A2 Use of the augmenter of liver regeneration protein as an apoptosis regulator |
| 02/24/2010 | EP2155231A1 Imaging and therapy of virus-associated tumors |
| 02/24/2010 | EP2155230A1 Methods and compositions for use of cyclic analogues of histatin |
| 02/24/2010 | EP2155229A2 Composition for transmucosal delivery of polypeptides |
| 02/24/2010 | EP2155228A1 Polypeptide inhibitors of hsp27 kinase and uses therefor |
| 02/24/2010 | EP2155227A1 New treatment for chemical substance addiction |
| 02/24/2010 | EP2155226A2 Compounds for inhibiting protein aggregation, and methods for making and using them |
| 02/24/2010 | EP2155206A1 Wound and cutaneous injury healing with a nucleic acid encoding a proteoglycan polypeptide |
| 02/24/2010 | EP2155176A2 Substrate promoting angiogenesis |
| 02/24/2010 | EP2155164A1 Self-precipitating pharmaceutical formulations for the modified release of active principle |
| 02/24/2010 | EP2154969A2 Treatment of synucleinopathies |
| 02/24/2010 | EP1928484B1 Methods for treatment of headaches by administration of oxytocin |
| 02/24/2010 | EP1869185B1 Conjugate comprising p21 protein for the treatment of cancer |
| 02/24/2010 | EP1687032B1 Pharmaceutical composition for treating unresectable, locally advanced pancreatic cancer (lapc). |
| 02/24/2010 | EP1620061B1 Antiviral agents for the treatment, control and prevention of infections by coronaviruses |
| 02/24/2010 | EP1572066B1 Novel method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within mmp-2 |
| 02/24/2010 | EP1553962B1 Combination chemotherapy with chlorotoxin |
| 02/24/2010 | EP1471936B1 Hiv vaccine and method of use |
| 02/24/2010 | EP1325130B1 Nogo receptor homologs |
| 02/24/2010 | EP1290011B1 Melphalan derivatives and their use as cancer chemotherapeutic drugs |
| 02/24/2010 | EP1112087B1 Hedgehog and patched antagonists for inhibiting cell and tissue growth and differentiation and uses therefor |
| 02/24/2010 | EP1007084B1 Immunogenic lhrh compositions and methods relating thereto |
| 02/24/2010 | EP0861261B9 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 02/24/2010 | EP0837696B1 Improved delivery of diagnostic and therapeutic agents to a target site |
| 02/24/2010 | CN101657212A Methods of use of TRK receptor modulators |
| 02/24/2010 | CN101657211A Use of lhrh antagonists for the treatment of lower urinary tract symptoms, in particular overactive bladder and/or detrusor overactivity |
| 02/24/2010 | CN101657210A Method of treating or preventing tissue deterioration, injury or damage due to disease of mucosa |
| 02/24/2010 | CN101654673A Rna interference mediating small rna molecules |
| 02/24/2010 | CN101654672A Rna interference mediating small rna molecules |
| 02/24/2010 | CN101654479A Mammalian receptor proteins, agents, and methods relating thereto |
| 02/24/2010 | CN101653602A Treatment, prophylaxis and diagnostic reagent of hepatitis b |
| 02/24/2010 | CN101653600A Drug controlling and preventing bee death owing to collecting camellia and camellia oil and preparation method thereof |
| 02/24/2010 | CN101653599A Treatment of demyelinating disorders with soluble lymphotoxin-beta-receptor |
| 02/24/2010 | CN101653598A Thymic peptide alpha1PLGA slow release microsphere preparation and method for preparing same |
| 02/24/2010 | CN101653597A Compound poplar flower oral liquid for treating piglet yellow or white dysentery and preparation thereof |
| 02/24/2010 | CN101653596A Soluble powder for treating canine colibacillosis and preparation method thereof |
| 02/24/2010 | CN101653595A Thymopeptide-5 suppository and preparation method thereof |
| 02/24/2010 | CN101653594A Somatostatin-dopamine chimeric analogs |
| 02/24/2010 | CN101653424A 高药物载荷片剂 High drug load tablets |
| 02/24/2010 | CN100591774C Process for manufacture of nematode-extracted anticoagulant protein (NAP) |
| 02/24/2010 | CN100591691C Anti-tumour compound |
| 02/24/2010 | CN100591689C Solid salts of benzazepine compounds and its uses in preparing pharmaceutical compound containing them |
| 02/24/2010 | CN100591686C CNGH0010 specific polynucleotides, polypeptides, antibodies, compositions, methods and uses |
| 02/24/2010 | CN100591354C Treatment of ophthalmic conditions |
| 02/23/2010 | US7667020 Nucleotide sequence coding receptor protein for detecting moderator of autoimmune disease; treat, prevent, or delay a tissue proliferation-associated disorder as rheumatoid arthritis and multiple sclerosis |
| 02/23/2010 | US7667019 Flea ultraspiracle nucleic acid molecules |
| 02/23/2010 | US7667015 Genetic engineering; induce immunology response; biodrug as anticarcinogenic agents, for pancreatic cancer |
| 02/23/2010 | US7667008 Heparin binding protein for use in controlling angiogenesis and as wound healing agent |
| 02/23/2010 | US7667005 Polypeptide, novel DNA and novel antibody |
| 02/23/2010 | US7667002 Peptides and proteins for early liver development and antibodies thereto |
| 02/23/2010 | US7667000 Antibodies to Zcytor 16 |
| 02/23/2010 | US7666999 Neutral amino acid transporter and gene thereof |
| 02/23/2010 | US7666998 Cell growth inhibitor containing anti-PepT antibody |
| 02/23/2010 | US7666996 Casein derived peptides and uses thereof |
| 02/23/2010 | US7666995 Interferons, uses and compositions related thereto |
| 02/23/2010 | US7666992 Pancreatic cancer genes |
| 02/23/2010 | US7666991 Compositions for needleless delivery of antibodies |
| 02/23/2010 | US7666989 Polynucleotide encoding the amino acid sequence; DNA sequence which encodes a protein; expression vector gene; cell line; multiple myeloma, leukemia, brain glioma, lung cancer and colon cancer |
| 02/23/2010 | US7666986 Biologically active peptide comprising tyrosyl-seryl-valine (YSV) |
| 02/23/2010 | US7666985 HLA-A24-restricted cancer antigen peptides |
| 02/23/2010 | US7666983 peptides that activate the DNA binding activity of the wild-type form of the p53 tumor suppressor, as well as of certain tumor-derived p53 mutants |
| 02/23/2010 | US7666910 Locating an artery which carries major blood supply to the tumor; intra-arterially injecting into the located artery a predetermined quantity of a polyunsaturated fatty acid solution and anti-antiogenic substances |
| 02/23/2010 | US7666858 Pharmaceutical composition for treatment of phimosis using topical corticosteroid |